Cognitive Behavioral Aggression Treatment
1 other identifier
interventional
120
1 country
1
Brief Summary
Aggressive behavior is a leading worldwide public health problem. Despite this, relatively little is known about how to best treat individuals who are highly angry and aggressive. A rich literature suggests that aggression is associated with a tendency to interpret situations as threatening or hostile even when they are not. This process is governed by a prefrontal-limbic circuit in the brain. A goal of cognitive behavioral therapy is to reduce these kinds of hostile biases. Preliminary data by the PI suggests a 12- session cognitive behavioral aggression treatment (CBAT) may help reduce aggressive behavior and underlying hostile biases associated with affective aggression. To assess the efficacy of this treatment, 120 adults with high levels of anger and aggression will receive 12 sessions of either CBAT or supportive psychotherapy. All subjects will monitor their anger and aggressive behavior throughout the treatment electronic diaries. Subjects will also complete questionnaires and computer tasks to assess anger, hostile biases and related processes 1-week before treatment begins, and again 1-week, 6-months and 1-year after treatment ends. In addition, to understand the effects of CBAT on the brain, subjects will have their brains scanned (functional Magnetic Resonance Imaging) while they look at emotional pictures and complete computer tasks. The brain scans will occur once before treatment starts and once after treatment ends. Our hypotheses are:
- 1.CBAT will reduce anger, aggression and hostile biases more than supportive therapy.
- 2.CBAT will decrease limbic activation and increase prefrontal activation to emotional pictures more than supportive therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started May 2010
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 20, 2010
CompletedFirst Posted
Study publicly available on registry
December 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedMarch 4, 2016
March 1, 2016
5.8 years
December 20, 2010
March 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aggressive Acts
Aggressive acts will be measured using electronic diaries and clinical interview
Pre-intervention thru 1 year post-intervention
Secondary Outcomes (1)
Brain activation to emotional stimuli
14 weeks
Study Arms (2)
Cognitive Behavioral Therapy
EXPERIMENTALTwelve weekly 50-minute sessions of individual cognitive behavioral aggression treatment
Supportive Psychotherapy
ACTIVE COMPARATORTwelve weekly 50-minute sessions of individual supportive (client-centered) psychotherapy
Interventions
Twelve weekly 50-minute sessions of individual cognitive behavioral aggression treatment or supportive psychotherapy
Eligibility Criteria
You may qualify if:
- Three or more acts of physical aggression (assault / property destruction) in past six months
- Aggression related distress and/or impairment
- Meets Criteria for Intermittent Explosive Disorder
You may not qualify if:
- Life History of DSM-IV Axis Bipolar disorder, Schizophrenia, Delusional disorder, Organic disorder, or Mental Retardation
- Current DSM-IV Major Depressive Episode, Alcohol Dependence or other Drug Dependence
- Current (past month) psychotropic medication use
- Current severe suicidal or homicidal ideation necessitating immediate medical intervention
- Current pregnancy or nursing, or existence of any medical condition that would deem the subject ineligible to undergo an fMRI (e.g., metal pins)
- Two consecutive positive Expired Breathalyzer Alcohol or Urine Drug toxicological screens
- Unable or unwilling to cooperate with study protocol (e.g., keep appointments, complete rating forms, read and understand informed consent).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Temple University
Philadelphia, Pennsylvania, 19122, United States
Related Publications (1)
McCloskey MS, Noblett KL, Deffenbacher JL, Gollan JK, Coccaro EF. Cognitive-behavioral therapy for intermittent explosive disorder: a pilot randomized clinical trial. J Consult Clin Psychol. 2008 Oct;76(5):876-86. doi: 10.1037/0022-006X.76.5.876.
PMID: 18837604BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael S McCloskey, Ph.D
Temple University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 20, 2010
First Posted
December 22, 2010
Study Start
May 1, 2010
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
March 4, 2016
Record last verified: 2016-03